Development of a Rapidly-acting Preventative Therapy for Influenza
Awarded Award Notice Posted
- Solicitation number
- HR001118S0037
- Agency
- Defense Advanced Research Projects Agency Department of Defense
- Awarded
- to Dnarx LLC
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- HR001119C0060 Federal contract award
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- PSC
- Not on record
Notice details come from SAM.gov. Updated .
Notice text
This is an award annoucement only under the PReemptive Expression of Protective Alleles and Response Elements (PREPARE) BAA. The BAA is closed.. Awarded Vendors: DNARX LLC. Contract Award Dollar Amount: $3,598,132 Base and $7,115,237 NTE Options. Contract Award Date: 2019-04-09.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Development of a Rapidly-acting Preventative Therapy for Influenza | Award Notice | |
| PReemptive Expression of Protective Alleles and Response Elements (PREPARE) | Pre-Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity